(Q37082107)

18 August 2017

1 reference

title

MRI for the differential diagnosis of neurodegenerative parkinsonism in clinical practice (English)

1 reference

magnetic resonance imaging

18 August 2017

0 references

1 reference

1 reference

0 references

parkinsonian syndrome

1 reference

1

Klaus Seppi

1 reference

18 August 2017

publication date

1 January 2007

1 reference

Parkinsonism and Related Disorders

18 August 2017

published in

1 reference

18 August 2017

volume

13 Suppl 3

1 reference

18 August 2017

page(s)

S400-5

1 reference

SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

The sensitivity of 18-fluorodopa positron emission tomography and magnetic resonance imaging in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

An update on conventional and advanced magnetic resonance imaging techniques in the differential diagnosis of neurodegenerative parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Multiple system atrophy (Shy-Drager syndrome): MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Voxel-based morphometry–the methods

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Cerebral atrophy and its relation to cognitive impairment in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Voxel-based analysis of multiple-system atrophy of cerebellar type: complementary results by combining voxel-based morphometry and voxel-based relaxometry

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

In Vivo Voxel-Based Morphometry in Multiple System Atrophy of the Cerebellar Type

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Progression of brain atrophy in multiple system atrophy. A longitudinal VBM study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

New and reliable MRI diagnosis for progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

MR imaging of middle cerebellar peduncle width: differentiation of multiple system atrophy from Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Looking into the functional architecture of the brain with diffusion MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Magnetisation transfer measurements of the subcortical grey and white matter in Parkinson's disease with and without dementia and in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Magnetization transfer measurements of brain structures in patients with multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Olfaction and Parkinson's syndromes: its role in differential diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Quantitative evaluation of brainstem involvement in multiple system atrophy by diffusion-weighted MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

In vivo 1H NMR spectroscopy of individual human brain metabolites at moderate field strengths.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under high-dose methylprednisolone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970038-5

7 January 2021

10.1016/S1353-8020(08)70038-5

Identifiers

DOI

1 reference

18 August 2017

1 reference